Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.
Miriam Kron, C James Howell, Ian T Adams, Michael Ransbottom, Diana Christian, Michael Ogier, David M Katz
Journal of Neuroscience October 3, 2012 DOI: 10.1523/jneurosci.2159-12.2012 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Wild-type and Mecp2-null mice, a model of Rett syndrome, at 3 and 6 weeks of age |
| Intervention | Ketamine |
| Measures | Fos labeling, whole-cell recordings of spontaneous and miniature EPSCs and evoked EPSCs, sensorimotor function |
| Topics | Default mode network Esketamine Ketamine |
| Key findings | At 6 weeks, Mecp2-null mice showed less Fos labeling than wild-type mice in limbic cortices and subcortical structures, including default mode network nodes, but more Fos labeling in hindbrain cardiorespiratory regions such as the nucleus tractus solitarius, where increased Fos was associated with synaptic hyperexcitability. No genotype differences were seen at 3 weeks. Ketamine reversed reduced forebrain Fos and abnormal sensorimotor function. The authors propose that default mode network hypofunction may be a shared, reversible feature of Rett syndrome and other autism spectrum disorders. |
Abstract
Excitatory-inhibitory imbalance has been identified within specific brain microcircuits in models of Rett syndrome (RTT) and other autism spectrum disorders (ASDs). However, macrocircuit dysfunction across the RTT brain as a whole has not been defined. To approach this issue, we mapped expression of the activity-dependent, immediate-early gene product Fos in the brains of wild-type (Wt) and methyl-CpG-binding protein 2 (Mecp2)-null (Null) mice, a model of RTT, before and after the appearance of overt symptoms (3 and 6 weeks of age, respectively). At 6 weeks, Null mice exhibit significantly less Fos labeling than Wt in limbic cortices and subcortical structures, including key nodes in the default mode network. In contrast, Null mice exhibit significantly more Fos labeling than Wt in the hindbrain, most notably in cardiorespiratory regions of the nucleus tractus solitarius (nTS). Using nTS as a model, whole-cell recordings demonstrated that increased Fos expression in Nulls at 6 weeks of age is associated with synaptic hyperexcitability, including increased frequency of spontaneous and miniature EPSCs and increased amplitude of evoked EPSCs in Nulls. No such effect of genotype on Fos or synaptic function was seen at 3 weeks. In the mutant forebrain, reduced Fos expression, as well as abnormal sensorimotor function, were reversed by the NMDA receptor antagonist ketamine. In light of recent findings that the default mode network is hypoactive in autism, our data raise the possibility that hypofunction within this meta-circuit is a shared feature of RTT and other ASDs and is reversible.
Comparable studies
Other preclinical and animal studies on default mode network, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Rat brains also have a default mode network Rats | 2012 | Observational study | |
| Large-scale topology and the default mode network in the mouse connectome Mouse brain | 2014 | Observational study | |
| Hippocampal Sharp-Wave Ripples Influence Selective Activation of the Default Mode Network Anesthetized monkeys | 2016 | Observational study | |
| Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats Healthy rats and a rat model of alcohol relapse | 2023 | Randomized, placebo-controlled crossover pharmaco-fMRI study | |
| Altered functional connectivity within the default mode network in two animal models with opposing episodic memories Rats (control, LPS-challenged, and footshock-exposed groups) | 2018 | Animal model study |
Citations in the library
Cited by 6
- Intravenous esketamine in pediatric Rett syndrome: An open-label, early phase 1 pilot study. Molecular therapy. Methods & clinical development March 13, 2025
- A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome. Journal of neurodevelopmental disorders January 24, 2025
- MeCP2 prevents against sustained ketamine-induced synaptic depression at inhibitory synapses. iScience June 20, 2025
- Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges Pharmacological Research August 26, 2026
- Autistic-like social deficits in hippocampal MeCP2 knockdown rat models are rescued by ketamine. BMB reports May 2022
and 1 more in the library
Cites 5
- A default mode of brain function Proceedings of the National Academy of Sciences January 16, 2001
- Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase Science December 6, 2007
- NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses Nature June 15, 2011
- Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications. The International Journal of Neuropsychopharmacology September 2009
- Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment. Journal of Neurochemistry November 2006